Effect of splenectomy on platelets associated antibodies in hepatitis C patients with thrombocytopenia

Hematology

Volumn 17, Issue 2, 2012, Pages 118-121

  Aref, Salah ^a   Ibrahem, Lamyaa ^a   El Menshawy, Nadia ^a   Bassam, Ansaf ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Splenectomy in hepatitis C

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN SUBCLASS;

ADULT; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; CHRONIC HEPATITIS; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTE COUNT;

ADULT; AUTOIMMUNITY; BLOOD PLATELETS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULINS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; SPLEEN; SPLENECTOMY; SPLENOMEGALY; THROMBOCYTOPENIA;

EID: 84862987018     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453312X13221316477705     Document Type: Article

References (24)

1. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS. The role of parentral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;341:556.
2. Marusawa H, Hijikata M, Chiba T, Shimotohno K. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-B activation. J Virol. 1999; 73(6):4713-4720.
3. Luo JC, Hwang SJ, Chang FY, Chu CW, Lai CR, Wang YJ, et al. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C. Hepatogastroenterology. 2002;49(44):478-481.
4. Srinivas D, Mani H, Crumpler C, Van Thiel DH. Daily interferon therapy for chronic hepatitis C: a report of a community practice experience. Hepatogastroenterology. 2002;49(46):1053-1057.
5. Calabrese F, Pontiso P, Perrenazzo E, Benvegnu L, Vario A, Chemello L, et al. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology. 2000;31:1153-1159.
6. Bantel H, Lugering A, Poremba C, Lugering N, Held J, Domschke W, et al. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology. 2001;34:758-867.
7. Wang C, Wang S, Chang T, Chou P. Strong association of hepatitis C virus infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection. Clin Infect Dis. 2004;39:790-796.
8. Giannini G. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther. 2006;23:1055-1065.
9. Aref S, Mabed M, Selim T, Goda T, Khafagy N. Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia. Hematology. 2004;9:351-356.
10. Weksler BB. Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease. Aliment Pharmacol Ther. 2007;26(Suppl. 1):13-19.
11. Louie KS, Micallef JM, Pimenta JM, Forssen UM. Prevalence of thrombocytopenia among chronic hepatitis C patients: a systematic review. J Viral Hepat. 2011;18:1-7.
12. Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK, et al. Portal Hypertension Collaborative Group. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol. 2009;7:689-695.
13. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of 'hypersplenic' thrombocytopenia. J Clin Invest. 1966;45: 645-657.
14. Sanyal AJ. The use and misuse of transjugular intrahepatic portasystemic shunts. Curr Gastroenterol Rep. 2000;2:61-71.
15. Noguchi H, Hirai K, Aoki Y, Sakata K, Tanikawa K. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism. Hepatology. 1995;22: 1682-1688.
16. Shah R, Mahour GH, Ford EG, Stanley P. Partial splenic embolization, An effective alternative to splenectomy for hypersplenism. Am Surg. 1990;56:774-777.
17. Koyanagi N, Iso Y, Higashi H, Kitano S, Sugimachi K. Increased platelet count as a screening test for distal splenorenal shunt patency. Am J Surg. 1988;156:29-33.
18. Yanaga K, Tzakis AG, Shimada M, Campbell WE, Marsh JW, Stieber AC, et al. Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg. 1989;210:180-183.
19. Sekiguchi T, Nagamine T, Takagi H, Mori M. Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C. World J Gastroenterol. 2006;12:1205-1210.
20. McMillan R, Tani P, Mason D. The demonstration of antibody binding to platelet-associated antigens in patients with immune thrombocytopenic purpura. Blood. 1980;56:993-995.
21. Sanjo A, Satoi J, Ohnicih A, Maruno J, Fukata M, Suzuki N. Role of elevated platelet associated IgG and hypersplenism in thrombocytopenia of chronic liver diseases. J Gasteroenterol Hepatol. 2003;18:638-644.
22. Panzer S, Seel E, Brunner M, Koromoczi GF, Schmid M, Ferenci P, et al. Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia. Eur J Hematol. 2006;77:513-517.
23. Dienstag JL, McHutchison JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology. 2006;130(1):231-264. quiz 214-7.
24. Olariu M, Olariu C, Olteanu D. Thrombocytopenia in chronic hepatitis C. J Gastrointest Liver Dis. 2010;19:381-385.